NCT04513951
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04513951 |
| Title | AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients (AVETRIC) |
| Acronym | AVETRIC |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Gruppo Oncologico del Nord-Ovest |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ITA |
CKB BOOST